196 related articles for article (PubMed ID: 23510773)
21. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
22. The need for HPV vaccination.
O'Connor MB; O'Connor C
Ir Med J; 2009 Jun; 102(6):193. PubMed ID: 19722363
[No Abstract] [Full Text] [Related]
23. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
[TBL] [Abstract][Full Text] [Related]
24. Rebuttal: Do you approve of spending $300 million on HPV vaccination? No.
Lippman A; Boscoe M; Scurfield C
Can Fam Physician; 2008 Mar; 54(3):343, 345. PubMed ID: 18337522
[No Abstract] [Full Text] [Related]
25. Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.
Van Minh H; My NTT; Jit M
BMC Health Serv Res; 2017 May; 17(1):353. PubMed ID: 28506297
[TBL] [Abstract][Full Text] [Related]
26. Writing for CON position: Should the HPV vaccine be mandatory for early adolescent girls?
Anderson TL
MCN Am J Matern Child Nurs; 2007; 32(4):209. PubMed ID: 17667282
[No Abstract] [Full Text] [Related]
27. Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
Kim JJ
PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363
[TBL] [Abstract][Full Text] [Related]
28. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
29. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
30. Human papillomavirus.
Brody H
Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432
[No Abstract] [Full Text] [Related]
31. HPV vaccination: Clinical potential, implementation challenges, and future directions.
Perkins RB
Hum Vaccin Immunother; 2016 Jun; 12(6):1327-31. PubMed ID: 27294609
[No Abstract] [Full Text] [Related]
32. Evaluating human papillomavirus vaccination programs.
Donovan B; Guy RJ
Sex Transm Dis; 2013 Apr; 40(4):290-1. PubMed ID: 23481536
[No Abstract] [Full Text] [Related]
33. Prophylactic and therapeutic human papillomavirus vaccine: a breakthrough for women health.
Yousuf S; Syed S
J Pak Med Assoc; 2009 May; 59(5):310-4. PubMed ID: 19438137
[TBL] [Abstract][Full Text] [Related]
34. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
35. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
Dillner J; Andrae B; Westermark B
Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
[No Abstract] [Full Text] [Related]
36. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.
Franco EL
BMJ; 2007 Aug; 335(7616):378-9. PubMed ID: 17717367
[No Abstract] [Full Text] [Related]
37. What works for human papillomavirus vaccine introduction in low and middle-income countries?
Howard N; Gallagher KE; Mounier-Jack S; Burchett HED; Kabakama S; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():22-25. PubMed ID: 29179865
[TBL] [Abstract][Full Text] [Related]
38. Policy debate over human papillomavirus vaccines.
Richman S
J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138
[No Abstract] [Full Text] [Related]
39. Development and impact of human papillomavirus vaccines.
Darus CJ; Mueller JJ
Clin Obstet Gynecol; 2013 Mar; 56(1):10-6. PubMed ID: 23314717
[TBL] [Abstract][Full Text] [Related]
40. HPV vaccine: implications for nurses and patients.
Schmidt JV
Nurs Womens Health; 2007 Feb; 11(1):83-7. PubMed ID: 17883822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]